Stocks Down Under Videos

Get a 3-month FREE TRIAL to CONCIERGE now!

Concierge gives you timely BUY and SELL alerts on ASX-listed stocks

Interview with Tim Oldham, CEO of AdAlta (ASX:1AD)

August 7, 2020


We talked with Dr. Tim Oldham about the prospects of AdAlta’s lead compound AD-214 as it enters the clinic for its first Phase 1 study, as well as the power of AdAlta’s i-body drug discovery platform.